In 2023, digital health fundraising took on a bit of a different shape, according to a new Rock Health report. Startups tried out some creative ways to keep their businesses afloat — including series extension rounds, unlabeled fundraises and silent deals from existing investors.
The digital health sector's quarterly investment trends seem to be stabilizing in 2023, according to a new report from Rock Health. The report noted investors are shifting their focus away from pandemic-era categories like telehealth and pharmaceutical R&D catalysts — instead, they're interested in startups creating products for disease treatment, the improvement of nonclinical workflows and the enablement of value-based care.
The digital health sector has entered a new era when it comes to funding, and startups in this space must quickly adjust to an investment landscape that is characterized by lower check sizes, fewer deals and smaller cohort of investors. If things continue at the pace the sector has maintained throughout the first half of the year, 2023 will mark the field's lowest yearly fundraising total since 2019, according to a new report.
Digital health’s Q3 saw the lowest quarterly funding total in the past 11 quarters, but experts don't think this trend should be a cause for concern. They said it's important to remember that the mega-boom of 2020 and 2021 was an anomaly for the sector.
While 2022 will likely be a reset from the tremendous growth in digital health funding of 2021, this is a healthy correction and an opportunity to realign on core metrics.
Digital health startups raised $10.3 billion across 329 deals during the first half of 2022. This putts the sector on track to rake in $21 billion this year, about $8 billion less than the total amount it raised in 2021. The market boom has ended, but the digital health investment space has not come crashing down by any means, according to a recent report.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
In a webinar sponsored by Wheel, health tech executives will explore how telehealth is increasingly becoming the first point of interaction between patients and providers and the potential for hybrid care models to improve the patient experience, health outcomes, and deliver cost savings.
Digital health companies have now raised more than $20 billion in 2021, more than any other year. While experts expect to see the dealmaking continue, they raised caution about the challenges of going public with high valuations.
According to Rock Health’s annual consumer adoption survey, telehealth users tend to be higher income, younger and live in urban areas. The survey also tracked people’s satisfaction with telehealth and what modalities people used most to access care.
Digital health funding broke records again as companies raised a total of $14.7 billion in the first half of the year. Several companies also went public, but those that have gone public since 2020 have recently underperformed the NASDAQ.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Digital health startups raised a record-breaking $6.7 billion in the first quarter of 2021. Large funding rounds propelled them past previous months.
A recent report by Rock Health found that Black and female founders of digital health companies received less funding and were more likely to bootstrap their companies than other groups.
Digital health companies once again set a record for funding in 2020, according to a report by Rock Health. They raised a total of $5.4 billion in the first half of the year.
A roundup of new developments spotlighting startups this week including HealCo, PatientWing, as well as new research from Rock Health.
Digital health startups raised a total of $3.1 billion in funding during the first quarter of 2020, according to a report released Monday by Rock Health. But startups face a dramatically different investing climate post-Covid-19.
